ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pediatric Drugs Market Research Report 2025
Published Date: 2025-09-02
|
Report Code: QYRE-Auto-5Y1406
Home | Market Reports | Health| Pharmacy
Global Pediatric Drugs Market Research Report 2020
BUY CHAPTERS

Global Pediatric Drugs Market Research Report 2025

Code: QYRE-Auto-5Y1406
Report
2025-09-02
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Bayer
Boehringer Ingelheim
Bristol–Myers Squibb
Colgate Oral Pharmaceuticals
Eli Lilly
Forest Laboratories
MedImmune
Merck
Novartis Pharmaceuticals
Pfizer Inc
Pharmacia
Roche
Schering Plough
GlaxoSmithKline
Genentech Inc
GlaxoSmithKline PLC
Johnson & Johnson
Novo Nordisk

Pediatric Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pediatric Drugs Market

Pediatric Drugs Market

The global market for Pediatric Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The market for pediatric pharmaceuticals has become an increasingly important tool in life-cycle management. However, line extensions using children’s formulations to increase patent life of existing adult dose drugs are only one of the drivers of this large, but little-studied market.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pediatric Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Drugs.
The Pediatric Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pediatric Drugs Market Report

Report Metric Details
Report Name Pediatric Drugs Market
CAGR 5%
Segment by Type
  • Allergy and Respiratory Drugs
  • Anti-Infectives
  • Cancer Therapies
  • Cardiovascular Drugs
  • Central Nervous System Drugs
  • Gastrointestinal Drugs
  • Hormone Drugs
  • Urological Drugs
Segment by Application
  • Hospital
  • Clinic
  • Drugstore
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott Laboratories, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Colgate Oral Pharmaceuticals, Eli Lilly, Forest Laboratories, Genentech, GlaxoSmithKline, Johnson & Johnson, MedImmune, Merck, Novartis Pharmaceuticals, Novo Nordisk, Pfizer, Pharmacia, Roche, Schering-Plough
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pediatric Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pediatric Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pediatric Drugs Market report?

Ans: The main players in the Pediatric Drugs Market are Abbott Laboratories, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Colgate Oral Pharmaceuticals, Eli Lilly, Forest Laboratories, Genentech, GlaxoSmithKline, Johnson & Johnson, MedImmune, Merck, Novartis Pharmaceuticals, Novo Nordisk, Pfizer, Pharmacia, Roche, Schering-Plough

What are the Application segmentation covered in the Pediatric Drugs Market report?

Ans: The Applications covered in the Pediatric Drugs Market report are Hospital, Clinic, Drugstore

What are the Type segmentation covered in the Pediatric Drugs Market report?

Ans: The Types covered in the Pediatric Drugs Market report are Allergy and Respiratory Drugs, Anti-Infectives, Cancer Therapies, Cardiovascular Drugs, Central Nervous System Drugs, Gastrointestinal Drugs, Hormone Drugs, Urological Drugs

1 Pediatric Drugs Market Overview
1.1 Product Definition
1.2 Pediatric Drugs by Type
1.2.1 Global Pediatric Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Allergy and Respiratory Drugs
1.2.3 Anti-Infectives
1.2.4 Cancer Therapies
1.2.5 Cardiovascular Drugs
1.2.6 Central Nervous System Drugs
1.2.7 Gastrointestinal Drugs
1.2.8 Hormone Drugs
1.2.9 Urological Drugs
1.3 Pediatric Drugs by Application
1.3.1 Global Pediatric Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.4 Global Pediatric Drugs Market Size Estimates and Forecasts
1.4.1 Global Pediatric Drugs Revenue 2020-2031
1.4.2 Global Pediatric Drugs Sales 2020-2031
1.4.3 Global Pediatric Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pediatric Drugs Market Competition by Manufacturers
2.1 Global Pediatric Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pediatric Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pediatric Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pediatric Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pediatric Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pediatric Drugs, Product Type & Application
2.7 Global Key Manufacturers of Pediatric Drugs, Date of Enter into This Industry
2.8 Global Pediatric Drugs Market Competitive Situation and Trends
2.8.1 Global Pediatric Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pediatric Drugs Players Market Share by Revenue
2.8.3 Global Pediatric Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pediatric Drugs Market Scenario by Region
3.1 Global Pediatric Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pediatric Drugs Sales by Region: 2020-2031
3.2.1 Global Pediatric Drugs Sales by Region: 2020-2025
3.2.2 Global Pediatric Drugs Sales by Region: 2026-2031
3.3 Global Pediatric Drugs Revenue by Region: 2020-2031
3.3.1 Global Pediatric Drugs Revenue by Region: 2020-2025
3.3.2 Global Pediatric Drugs Revenue by Region: 2026-2031
3.4 North America Pediatric Drugs Market Facts & Figures by Country
3.4.1 North America Pediatric Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pediatric Drugs Sales by Country (2020-2031)
3.4.3 North America Pediatric Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pediatric Drugs Market Facts & Figures by Country
3.5.1 Europe Pediatric Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pediatric Drugs Sales by Country (2020-2031)
3.5.3 Europe Pediatric Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Pediatric Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pediatric Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Pediatric Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pediatric Drugs Market Facts & Figures by Country
3.7.1 Latin America Pediatric Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pediatric Drugs Sales by Country (2020-2031)
3.7.3 Latin America Pediatric Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pediatric Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pediatric Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pediatric Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pediatric Drugs Sales by Type (2020-2031)
4.1.1 Global Pediatric Drugs Sales by Type (2020-2025)
4.1.2 Global Pediatric Drugs Sales by Type (2026-2031)
4.1.3 Global Pediatric Drugs Sales Market Share by Type (2020-2031)
4.2 Global Pediatric Drugs Revenue by Type (2020-2031)
4.2.1 Global Pediatric Drugs Revenue by Type (2020-2025)
4.2.2 Global Pediatric Drugs Revenue by Type (2026-2031)
4.2.3 Global Pediatric Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Pediatric Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pediatric Drugs Sales by Application (2020-2031)
5.1.1 Global Pediatric Drugs Sales by Application (2020-2025)
5.1.2 Global Pediatric Drugs Sales by Application (2026-2031)
5.1.3 Global Pediatric Drugs Sales Market Share by Application (2020-2031)
5.2 Global Pediatric Drugs Revenue by Application (2020-2031)
5.2.1 Global Pediatric Drugs Revenue by Application (2020-2025)
5.2.2 Global Pediatric Drugs Revenue by Application (2026-2031)
5.2.3 Global Pediatric Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Pediatric Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Company Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Laboratories Pediatric Drugs Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Pediatric Drugs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Pediatric Drugs Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Company Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bristol-Myers Squibb Pediatric Drugs Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 Colgate Oral Pharmaceuticals
6.5.1 Colgate Oral Pharmaceuticals Company Information
6.5.2 Colgate Oral Pharmaceuticals Description and Business Overview
6.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Colgate Oral Pharmaceuticals Pediatric Drugs Product Portfolio
6.5.5 Colgate Oral Pharmaceuticals Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Company Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lilly Pediatric Drugs Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Forest Laboratories
6.7.1 Forest Laboratories Company Information
6.7.2 Forest Laboratories Description and Business Overview
6.7.3 Forest Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Forest Laboratories Pediatric Drugs Product Portfolio
6.7.5 Forest Laboratories Recent Developments/Updates
6.8 Genentech
6.8.1 Genentech Company Information
6.8.2 Genentech Description and Business Overview
6.8.3 Genentech Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Genentech Pediatric Drugs Product Portfolio
6.8.5 Genentech Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Company Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GlaxoSmithKline Pediatric Drugs Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Company Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Johnson & Johnson Pediatric Drugs Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 MedImmune
6.11.1 MedImmune Company Information
6.11.2 MedImmune Description and Business Overview
6.11.3 MedImmune Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 MedImmune Pediatric Drugs Product Portfolio
6.11.5 MedImmune Recent Developments/Updates
6.12 Merck
6.12.1 Merck Company Information
6.12.2 Merck Description and Business Overview
6.12.3 Merck Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merck Pediatric Drugs Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Novartis Pharmaceuticals
6.13.1 Novartis Pharmaceuticals Company Information
6.13.2 Novartis Pharmaceuticals Description and Business Overview
6.13.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Novartis Pharmaceuticals Pediatric Drugs Product Portfolio
6.13.5 Novartis Pharmaceuticals Recent Developments/Updates
6.14 Novo Nordisk
6.14.1 Novo Nordisk Company Information
6.14.2 Novo Nordisk Description and Business Overview
6.14.3 Novo Nordisk Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Novo Nordisk Pediatric Drugs Product Portfolio
6.14.5 Novo Nordisk Recent Developments/Updates
6.15 Pfizer
6.15.1 Pfizer Company Information
6.15.2 Pfizer Description and Business Overview
6.15.3 Pfizer Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Pfizer Pediatric Drugs Product Portfolio
6.15.5 Pfizer Recent Developments/Updates
6.16 Pharmacia
6.16.1 Pharmacia Company Information
6.16.2 Pharmacia Description and Business Overview
6.16.3 Pharmacia Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Pharmacia Pediatric Drugs Product Portfolio
6.16.5 Pharmacia Recent Developments/Updates
6.17 Roche
6.17.1 Roche Company Information
6.17.2 Roche Description and Business Overview
6.17.3 Roche Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Roche Pediatric Drugs Product Portfolio
6.17.5 Roche Recent Developments/Updates
6.18 Schering-Plough
6.18.1 Schering-Plough Company Information
6.18.2 Schering-Plough Description and Business Overview
6.18.3 Schering-Plough Pediatric Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Schering-Plough Pediatric Drugs Product Portfolio
6.18.5 Schering-Plough Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Drugs Industry Chain Analysis
7.2 Pediatric Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Drugs Production Mode & Process Analysis
7.4 Pediatric Drugs Sales and Marketing
7.4.1 Pediatric Drugs Sales Channels
7.4.2 Pediatric Drugs Distributors
7.5 Pediatric Drugs Customer Analysis
8 Pediatric Drugs Market Dynamics
8.1 Pediatric Drugs Industry Trends
8.2 Pediatric Drugs Market Drivers
8.3 Pediatric Drugs Market Challenges
8.4 Pediatric Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Bayer
Boehringer Ingelheim
Bristol–Myers Squibb
Colgate Oral Pharmaceuticals
Eli Lilly
Forest Laboratories
MedImmune
Merck
Novartis Pharmaceuticals
Pfizer Inc
Pharmacia
Roche
Schering Plough
GlaxoSmithKline
Genentech Inc
GlaxoSmithKline PLC
Johnson & Johnson
Novo Nordisk
List of Tables
 Table 1. Global Pediatric Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pediatric Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pediatric Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pediatric Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pediatric Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pediatric Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pediatric Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pediatric Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pediatric Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pediatric Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pediatric Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Pediatric Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pediatric Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pediatric Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pediatric Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pediatric Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Pediatric Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pediatric Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Pediatric Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pediatric Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Pediatric Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pediatric Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Pediatric Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pediatric Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pediatric Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pediatric Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pediatric Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pediatric Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pediatric Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pediatric Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pediatric Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pediatric Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pediatric Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pediatric Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pediatric Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pediatric Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pediatric Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pediatric Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pediatric Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pediatric Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pediatric Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pediatric Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pediatric Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pediatric Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pediatric Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pediatric Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pediatric Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pediatric Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Pediatric Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Pediatric Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Pediatric Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Pediatric Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pediatric Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pediatric Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Pediatric Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Pediatric Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Pediatric Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Pediatric Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Pediatric Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Pediatric Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Pediatric Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Pediatric Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pediatric Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pediatric Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Pediatric Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Pediatric Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Pediatric Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. Abbott Laboratories Company Information
 Table 71. Abbott Laboratories Description and Business Overview
 Table 72. Abbott Laboratories Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Laboratories Pediatric Drugs Product
 Table 74. Abbott Laboratories Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Bayer Pediatric Drugs Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim Pediatric Drugs Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Bristol-Myers Squibb Company Information
 Table 86. Bristol-Myers Squibb Description and Business Overview
 Table 87. Bristol-Myers Squibb Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Bristol-Myers Squibb Pediatric Drugs Product
 Table 89. Bristol-Myers Squibb Recent Developments/Updates
 Table 90. Colgate Oral Pharmaceuticals Company Information
 Table 91. Colgate Oral Pharmaceuticals Description and Business Overview
 Table 92. Colgate Oral Pharmaceuticals Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Colgate Oral Pharmaceuticals Pediatric Drugs Product
 Table 94. Colgate Oral Pharmaceuticals Recent Developments/Updates
 Table 95. Eli Lilly Company Information
 Table 96. Eli Lilly Description and Business Overview
 Table 97. Eli Lilly Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Eli Lilly Pediatric Drugs Product
 Table 99. Eli Lilly Recent Developments/Updates
 Table 100. Forest Laboratories Company Information
 Table 101. Forest Laboratories Description and Business Overview
 Table 102. Forest Laboratories Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Forest Laboratories Pediatric Drugs Product
 Table 104. Forest Laboratories Recent Developments/Updates
 Table 105. Genentech Company Information
 Table 106. Genentech Description and Business Overview
 Table 107. Genentech Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Genentech Pediatric Drugs Product
 Table 109. Genentech Recent Developments/Updates
 Table 110. GlaxoSmithKline Company Information
 Table 111. GlaxoSmithKline Description and Business Overview
 Table 112. GlaxoSmithKline Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. GlaxoSmithKline Pediatric Drugs Product
 Table 114. GlaxoSmithKline Recent Developments/Updates
 Table 115. Johnson & Johnson Company Information
 Table 116. Johnson & Johnson Description and Business Overview
 Table 117. Johnson & Johnson Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Johnson & Johnson Pediatric Drugs Product
 Table 119. Johnson & Johnson Recent Developments/Updates
 Table 120. MedImmune Company Information
 Table 121. MedImmune Description and Business Overview
 Table 122. MedImmune Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. MedImmune Pediatric Drugs Product
 Table 124. MedImmune Recent Developments/Updates
 Table 125. Merck Company Information
 Table 126. Merck Description and Business Overview
 Table 127. Merck Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Merck Pediatric Drugs Product
 Table 129. Merck Recent Developments/Updates
 Table 130. Novartis Pharmaceuticals Company Information
 Table 131. Novartis Pharmaceuticals Description and Business Overview
 Table 132. Novartis Pharmaceuticals Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Novartis Pharmaceuticals Pediatric Drugs Product
 Table 134. Novartis Pharmaceuticals Recent Developments/Updates
 Table 135. Novo Nordisk Company Information
 Table 136. Novo Nordisk Description and Business Overview
 Table 137. Novo Nordisk Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Novo Nordisk Pediatric Drugs Product
 Table 139. Novo Nordisk Recent Developments/Updates
 Table 140. Pfizer Company Information
 Table 141. Pfizer Description and Business Overview
 Table 142. Pfizer Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Pfizer Pediatric Drugs Product
 Table 144. Pfizer Recent Developments/Updates
 Table 145. Pharmacia Company Information
 Table 146. Pharmacia Description and Business Overview
 Table 147. Pharmacia Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Pharmacia Pediatric Drugs Product
 Table 149. Pharmacia Recent Developments/Updates
 Table 150. Roche Company Information
 Table 151. Roche Description and Business Overview
 Table 152. Roche Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Roche Pediatric Drugs Product
 Table 154. Roche Recent Developments/Updates
 Table 155. Schering-Plough Company Information
 Table 156. Schering-Plough Description and Business Overview
 Table 157. Schering-Plough Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 158. Schering-Plough Pediatric Drugs Product
 Table 159. Schering-Plough Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Pediatric Drugs Distributors List
 Table 163. Pediatric Drugs Customers List
 Table 164. Pediatric Drugs Market Trends
 Table 165. Pediatric Drugs Market Drivers
 Table 166. Pediatric Drugs Market Challenges
 Table 167. Pediatric Drugs Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pediatric Drugs
 Figure 2. Global Pediatric Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pediatric Drugs Market Share by Type: 2024 & 2031
 Figure 4. Allergy and Respiratory Drugs Product Picture
 Figure 5. Anti-Infectives Product Picture
 Figure 6. Cancer Therapies Product Picture
 Figure 7. Cardiovascular Drugs Product Picture
 Figure 8. Central Nervous System Drugs Product Picture
 Figure 9. Gastrointestinal Drugs Product Picture
 Figure 10. Hormone Drugs Product Picture
 Figure 11. Urological Drugs Product Picture
 Figure 12. Global Pediatric Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 13. Global Pediatric Drugs Market Share by Application: 2024 & 2031
 Figure 14. Hospital
 Figure 15. Clinic
 Figure 16. Drugstore
 Figure 17. Global Pediatric Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Pediatric Drugs Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Pediatric Drugs Sales (2020-2031) & (K Units)
 Figure 20. Global Pediatric Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 21. Pediatric Drugs Report Years Considered
 Figure 22. Pediatric Drugs Sales Share by Manufacturers in 2024
 Figure 23. Global Pediatric Drugs Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Pediatric Drugs Players: Market Share by Revenue in Pediatric Drugs in 2024
 Figure 25. Pediatric Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Pediatric Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Pediatric Drugs Sales Market Share by Country (2020-2031)
 Figure 28. North America Pediatric Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Pediatric Drugs Sales Market Share by Country (2020-2031)
 Figure 32. Europe Pediatric Drugs Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Pediatric Drugs Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Pediatric Drugs Revenue Market Share by Region (2020-2031)
 Figure 40. China Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Pediatric Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Pediatric Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Pediatric Drugs Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Pediatric Drugs Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. U.A.E Pediatric Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Pediatric Drugs by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Pediatric Drugs by Type (2020-2031)
 Figure 62. Global Pediatric Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Pediatric Drugs by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Pediatric Drugs by Application (2020-2031)
 Figure 65. Global Pediatric Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 66. Pediatric Drugs Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions